We analysed drug combinations through a 5 × 5 matrix design and a self-generated seven-ray design based on the respective IC50 concentrations of the combination partners for antiproliferative synergy in the 6 MYC(N)-amplified MB and NB cell lines. Here, MYC is linked to neuroblastoma.